☆ 4.8 Letter

8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study)

JOURNAL OF HEPATOLOGY (2019)

Journal

JOURNAL OF HEPATOLOGY

Volume 70, Issue 3, Pages 554-557

Publisher

ELSEVIER

DOI: 10.1016/j.jhep.2018.10.032

Keywords

-

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.